Wet Labs & Plasma Fractionation Processing

Los Angeles, CA

Client: Baxter Healthcare

Since 2000, the biopharmaceutical has retained TWG to renovate biologically-sensitive laboratories and the blood-processing areas where fractionation takes place -- the process of breaking down plasma into its components. Baxter leads the field in the research and treatment of primary immunodeficiency and of hemophilia, a commonly-inherited blood-clotting disorder that rarely expresses itself in females but occurs once in every 5,000 newborn males worldwide.

To prevent the widespread transmission of blood-borne pathogens (HIV, HBV, HCV) which ravaged the U.S. hemophilia community in the 1980s, the company was the first to develop a therapy without human- or animal-derived additives. Construction is often accomplished during plant-wide shutdowns when building can proceed 24/7 for an approximate three-week period. TWG is particularly attuned to respond immediately to all questions in the field or any inspector-related issues. Many of our projects at Baxter involve working in concert with CRB Engineers.